Dilaudid and Bortezomib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dilaudid (hydromorphone hydrochloride) and Bortezomib (bortezomib). Common drug interactions include febrile neutropenia among females and infection among males.

The phase IV clinical study analyzes what interactions people have when they take Dilaudid and Bortezomib. It is created by eHealthMe based on reports of 73 people who take the same drugs from the FDA, and is updated regularly.

What is Dilaudid?

Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.

What is Bortezomib?

Bortezomib has active ingredients of bortezomib. eHealthMe is studying from 30,912 Bortezomib users. Check the latest studies of Bortezomib.

On Jul, 16, 2026

73 people who take Dilaudid and Bortezomib together, and have interactions are studied.

Dilaudid and Bortezomib drug interactions.

What are the common drug interactions of Dilaudid and Bortezomib, by gender? *:

female:

Febrile neutropenia (fever with reduced white blood cells)
Plasma cell myeloma (cancer that begins in plasma cells)
Pneumonia
Arthralgia (joint pain)
Asthenia (weakness)
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Osteomyelitis (infection of bone)
Platelet count decreased
Pyelonephritis (inflammation of kidney caused by bacteria)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

male:

Infection
Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
Amyloidosis (a tumour within which amyloid is produced)
Anaemia (lack of blood)
Arthralgia (joint pain)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Carpal tunnel syndrome (nerve compression at wrist results numbness weakness, pain , swelling)
Cataract (clouding of the lens inside the eye)
Conjunctivitis allergic (inflammation of the conjunctiva due to allergy)

What are the common drug interactions of Dilaudid and Bortezomib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Apnoea (suspension of external breathing)
Blood culture positive
Citrobacter test positive
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Klebsiella test positive
Pyrexia (fever)
Unresponsive to stimuli
Vomiting

40-49:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Alopecia (absence of hair from areas of the body)
Anaemia (lack of blood)
Blood creatinine increased
Cellulitis (infection under the skin)
Chills (felling of cold)
Cough
Decreased appetite
Device related infection
Fatigue (feeling of tiredness)

50-59:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Osteonecrosis (death of bone)
Pneumonia
Febrile neutropenia (fever with reduced white blood cells)
Chills (felling of cold)
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Muscle haemorrhage (bleeding in muscle)
Pyelonephritis (inflammation of kidney caused by bacteria)
Pyrexia (fever)
Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream)

60+:

Pneumonia
Cystitis (inflammation of the wall of the bladder)
Neuropathy peripheral (surface nerve damage)
Abdominal pain
Bone marrow failure
Drug ineffective
Intestinal obstruction
Metastatic malignant melanoma (spreadable cancer tumour of melanine)
Pulmonary embolism (blockage of the main artery of the lung)
Thrombosis (formation of a blood clot inside a blood vessel)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 48 people, 65.75%
Respiratory Distress (difficulty in breathing): 6 people, 8.22%
Faeces Hard: 6 people, 8.22%
Dental Caries: 6 people, 8.22%
Asthma: 6 people, 8.22%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 6 people, 8.22%
Constipation: 5 people, 6.85%
Waldenstrom's Macroglobulinaemia (cancer affects small lymphocytes (white blood cells)): 4 people, 5.48%
Neuropathy Peripheral (surface nerve damage): 4 people, 5.48%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 4 people, 5.48%

* Approximation only. Some reports may have incomplete information.

Do you take Dilaudid and Bortezomib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously